The inhibitory effects in vitro of phenothiazines and other drugs on lipid-peroxidation systems...

Por Slater, T. F.
Publicado em 1968

Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?

Por Kalsi, Sarbjeet S, Wood, David M, Waring, W Stephen, Dargan, Paul I
Publicado no Open Access Emerg Med (2011)

Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects

Por Ushijima, Kentarou, Tsuruoka, Shu-ichi, Tsuda, Hidetoshi, Hasegawa, Gohki, Obi, Yuri, Kaneda, Tae, Takahashi, Masaki, Maekawa, Tomohiro, Sasaki, Tomohiro, Koshimizu, Taka-aki, Fujimura, Akio
Publicado em 2009

Quantum mechanics implementation in drug-design workflows: does it really help?

Por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado no Drug Des Devel Ther (2017)

Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview

Por Singh, Divya, Cho, William C., Upadhyay, Ghanshyam
Publicado no Front Physiol (2016)

Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver

Por Rojas-Feria, María, Castro, Manuel, Suárez, Emilio, Ampuero, Javier, Romero-Gómez, Manuel
Publicado em 2013

Hepatitis E Virus Detection in Liver Tissue from Patients with Suspected Drug-Induced Liver Injury

Por Chijioke, Obinna, Bawohl, Marion, Springer, Erik, Weber, Achim
Publicado no Front Med (Lausanne) (2015)

Quantum mechanics implementation in drug-design workflows: does it really help? [Corrigendum]

Publicado no Drug Des Devel Ther (2017)

Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes

Por Zhou, Shufeng, Chin, Rebecca, Kestell, Philip, Tingle, Malcolm D, Paxton, James W
Publicado em 2001

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

Por López-Riera, Mireia, Conde, Isabel, Tolosa, Laia, Zaragoza, Ángela, Castell, José V., Gómez-Lechón, María J., Jover, Ramiro
Publicado no Front Pharmacol (2017)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion

Por Weersink, Rianne A, Bouma, Margriet, Burger, David M, Drenth, Joost P H, Hunfeld, Nicole G M, Kranenborg, Minke, Monster-Simons, Margje H, van Putten, Sandra A W, Metselaar, Herold J, Taxis, Katja, Borgsteede, Sander D
Publicado no BMJ Open (2016)

Correction possibilities of drug-induced liver toxicity in the treatment of patients with blood system tumors

Por V. B. Larionova, A. V. Snegovoy
Publicado em 2020-12-01

Diffusion-weighted MRI in staging of post hepatitis C fibrosis: does ADC value challenge liver biopsy?

Por Dena Serag, Eman Ragab
Publicado em 2020-09-01

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury

Por Woodhead, Jeffrey L., Yang, Kyunghee, Siler, Scott Q., Watkins, Paul B., Brouwer, Kim L. R., Barton, Hugh A., Howell, Brett A.
Publicado no Front Pharmacol (2014)

The Role of Bile Salt Export Pump Gene Repression in Drug-Induced Cholestatic Liver Toxicity

Por Garzel, Brandy, Yang, Hui, Zhang, Lei, Huang, Shiew-Mei, Polli, James E., Wang, Hongbing
Publicado em 2014

Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment

Por Teschke, Rolf, Wolff, Albrecht, Frenzel, Christian, Schwarzenboeck, Alexander, Schulze, Johannes, Eickhoff, Axel
Publicado em 2014

HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians

Por Petros, Zelalem, Kishikawa, Junko, Makonnen, Eyasu, Yimer, Getnet, Habtewold, Abiy, Aklillu, Eleni
Publicado no Front Pharmacol (2017)

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Por Cansu, Döndü Üsküdar, Güncan, Sabri, Bilge, N. Şule Yaşar, Kaşifoğlu, Timuçin, Korkmaz, Cengiz
Publicado no Eur J Rheumatol (2014)

A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts

Por Pizzo, Fabiola, Lombardo, Anna, Manganaro, Alberto, Benfenati, Emilio
Publicado no Front Pharmacol (2016)

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does...

Por Kim, Choon Ok, Oh, Eun Sil, Kim, Hohyun, Park, Min Soo
Publicado no Drug Des Devel Ther (2017)